缬昔洛韦对老年低钠血症患者的神经毒性和肾毒性。

IF 2 Q3 PHARMACOLOGY & PHARMACY
Drug Target Insights Pub Date : 2018-06-25 eCollection Date: 2018-01-01 DOI:10.1177/1177392818782899
Takuya Murakami, Tetsu Akimoto, Mari Okada, Erika Hishida, Taro Sugase, Atsushi Miki, Marina Kohara, Hiromichi Yoshizawa, Takahiro Masuda, Takahisa Kobayashi, Osamu Saito, Shigeaki Muto, Daisuke Nagata
{"title":"缬昔洛韦对老年低钠血症患者的神经毒性和肾毒性。","authors":"Takuya Murakami,&nbsp;Tetsu Akimoto,&nbsp;Mari Okada,&nbsp;Erika Hishida,&nbsp;Taro Sugase,&nbsp;Atsushi Miki,&nbsp;Marina Kohara,&nbsp;Hiromichi Yoshizawa,&nbsp;Takahiro Masuda,&nbsp;Takahisa Kobayashi,&nbsp;Osamu Saito,&nbsp;Shigeaki Muto,&nbsp;Daisuke Nagata","doi":"10.1177/1177392818782899","DOIUrl":null,"url":null,"abstract":"<p><p>A 66-year-old women with no history of renal disease was admitted due to a coma and acute kidney injury with a serum creatinine level of 7.44 mg/dL which were ascribed to valacyclovir neurotoxicity and nephrotoxicity, respectively. She had received valacyclovir at a standard dosage for the treatment of herpes zoster and was finally discharged, having fully returned to her normal baseline mental status with a recovered serum creatinine level of 0.68 mg/dL. We feel that awareness of this pathology remains a challenge for physicians and therefore strongly recommend the further accumulation of experiences similar to our own. Our experience underscores the pitfalls of administering valacyclovir to elderly patients who barely appear to have a favorable renal function. Several concerns regarding the therapeutic management, including blood purification strategies, that emerged in this case are also discussed.</p>","PeriodicalId":11326,"journal":{"name":"Drug Target Insights","volume":"12 ","pages":"1177392818782899"},"PeriodicalIF":2.0000,"publicationDate":"2018-06-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1177/1177392818782899","citationCount":"7","resultStr":"{\"title\":\"Valacyclovir Neurotoxicity and Nephrotoxicity in an Elderly Patient Complicated by Hyponatremia.\",\"authors\":\"Takuya Murakami,&nbsp;Tetsu Akimoto,&nbsp;Mari Okada,&nbsp;Erika Hishida,&nbsp;Taro Sugase,&nbsp;Atsushi Miki,&nbsp;Marina Kohara,&nbsp;Hiromichi Yoshizawa,&nbsp;Takahiro Masuda,&nbsp;Takahisa Kobayashi,&nbsp;Osamu Saito,&nbsp;Shigeaki Muto,&nbsp;Daisuke Nagata\",\"doi\":\"10.1177/1177392818782899\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>A 66-year-old women with no history of renal disease was admitted due to a coma and acute kidney injury with a serum creatinine level of 7.44 mg/dL which were ascribed to valacyclovir neurotoxicity and nephrotoxicity, respectively. She had received valacyclovir at a standard dosage for the treatment of herpes zoster and was finally discharged, having fully returned to her normal baseline mental status with a recovered serum creatinine level of 0.68 mg/dL. We feel that awareness of this pathology remains a challenge for physicians and therefore strongly recommend the further accumulation of experiences similar to our own. Our experience underscores the pitfalls of administering valacyclovir to elderly patients who barely appear to have a favorable renal function. Several concerns regarding the therapeutic management, including blood purification strategies, that emerged in this case are also discussed.</p>\",\"PeriodicalId\":11326,\"journal\":{\"name\":\"Drug Target Insights\",\"volume\":\"12 \",\"pages\":\"1177392818782899\"},\"PeriodicalIF\":2.0000,\"publicationDate\":\"2018-06-25\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.1177/1177392818782899\",\"citationCount\":\"7\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Drug Target Insights\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1177/1177392818782899\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2018/1/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"Q3\",\"JCRName\":\"PHARMACOLOGY & PHARMACY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Drug Target Insights","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1177/1177392818782899","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2018/1/1 0:00:00","PubModel":"eCollection","JCR":"Q3","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 7

摘要

66岁女性,无肾脏病史,因昏迷和急性肾损伤入院,血清肌酐水平为7.44 mg/dL,分别归因于伐昔洛韦神经毒性和肾毒性。她接受了标准剂量的缬昔洛韦治疗带状疱疹,最终出院,完全恢复到正常的基线精神状态,血清肌酐水平恢复到0.68 mg/dL。我们认为,对这种病理的认识对医生来说仍然是一个挑战,因此强烈建议进一步积累类似于我们自己的经验。我们的经验强调了将valacyclovir用于几乎没有良好肾功能的老年患者的陷阱。关于治疗管理的几个问题,包括血液净化策略,出现在这种情况下也进行了讨论。
本文章由计算机程序翻译,如有差异,请以英文原文为准。

Valacyclovir Neurotoxicity and Nephrotoxicity in an Elderly Patient Complicated by Hyponatremia.

Valacyclovir Neurotoxicity and Nephrotoxicity in an Elderly Patient Complicated by Hyponatremia.

Valacyclovir Neurotoxicity and Nephrotoxicity in an Elderly Patient Complicated by Hyponatremia.

A 66-year-old women with no history of renal disease was admitted due to a coma and acute kidney injury with a serum creatinine level of 7.44 mg/dL which were ascribed to valacyclovir neurotoxicity and nephrotoxicity, respectively. She had received valacyclovir at a standard dosage for the treatment of herpes zoster and was finally discharged, having fully returned to her normal baseline mental status with a recovered serum creatinine level of 0.68 mg/dL. We feel that awareness of this pathology remains a challenge for physicians and therefore strongly recommend the further accumulation of experiences similar to our own. Our experience underscores the pitfalls of administering valacyclovir to elderly patients who barely appear to have a favorable renal function. Several concerns regarding the therapeutic management, including blood purification strategies, that emerged in this case are also discussed.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Drug Target Insights
Drug Target Insights PHARMACOLOGY & PHARMACY-
CiteScore
2.70
自引率
0.00%
发文量
5
审稿时长
8 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信